Dutch biotech Kiadis Pharma appointed Ray Barlow as chief business officer. Barlow most recently led UK-based data-driven drug discovery company E-therapeutics as its CEO. His prior roles include serving at Amgen (NASDAQ: AMGN) as executive director of corporate development and at Crucell Vaccines, a Netherlands-based company that’s now a subsidiary of Johnson & Johnson (NASDAQ: JNJ).
Kiadis, a clinical-stage firm, is developing cell therapies based on natural killer cells to treat cancers.
Sponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
Brex
From Our Editors · Podcast
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex
